Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2023 Earnings Call Transcript August 7, 2023 5:00 PM ET

Company Participants

Debra Hart - Head of IR

Carl Hull - Executive Chairman of the Board

Trey Martin - CEO

Kevin Herde - CFO

Becky Buzzeo - CCO

Drew Burch - EVP, and GM Nucleic Acid Production

Conference Call Participants

Matt Sykes - Goldman Sachs

Conor McNamara - RBC Capital Markets

Dan Leonard - Credit Suisse

Catherine Schulte - Baird

Justin Bowers - Deutsche Bank

Tejas Savant - Morgan Stanley

Madeline Mollman - William Blair

John Sourbeer - UBS

Operator

Thank you for standing by. I would like to welcome everyone to the Quarter Two 2023 Maravai LifeSciences' Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. I will now turn the conference over to Debra Hart. Deb, please go ahead.

Debra Hart

Good afternoon, everyone. Thanks for joining us on our second quarter 2023 earnings call. Our press release and the slides that accompany today's call are posted on our website and are available at investors.maravai.com.

As you can see on our agenda on Slide 2, joining me today are Trey Martin, our new CEO, Kevin Herde, Chief Financial Officer, and Carl Hull, Executive Chairman of the Board. Drew Burch, Executive Vice President and General Manager of our Nucleic Acid Products, and Becky Buzzeo, our Chief Commercial Officer, will join the call for the question-and-answer session following the prepared remarks.

We remind you, management will make forward-looking statements and refer to GAAP and non-GAAP financial measures during today's call. It's possible that actual results could differ from management's expectations. We refer you to Slide 3 for more details on the forward-looking statements and our use of non-GAAP financial measures. Our just issued press release provides reconciliations to the most directly comparable GAAP measures. Please also refer to Maravai's SEC filings for additional information on the risks and uncertainties that may impact our operating results, performance and financial condition.

Now I'll turn the call over to Carl.

Carl Hull

Well, thank you, Deb, and good afternoon, everyone. We appreciate having you join us for our call today. During this call, we will provide the details of our financial results for the last quarter and our updated guidance. But first, I want to officially introduce and welcome Maravai's new CEO, Trey Martin, who took over his role on July 27.